Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitor11CRESTOR is a trademark, the property of AstraZeneca PLC. Research discussed in this article was supported by AstraZeneca.-Reference-Cited by-同舟云学术

Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitor11CRESTOR is a trademark, the property of AstraZeneca PLC. Research discussed in this article was supported by AstraZeneca.

Published:2001-03 Issue:5 Volume:87 Page:28-32
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

McTaggart Fergus,Buckett Linda,Davidson Robert,Holdgate Geoffry,McCormick Alex,Schneck Dennis,Smith Graham,Warwick Michael

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference8 articles.

1. Lowering LDL cholesterol;Gotto;Circulation,1999

2. Selectivity of ZD4522 for inhibition of cholesterol synthesis in hepatic versus non-hepatic cells;Buckett;Atherosclerosis,2000

3. Pharmacological properties of ZD4522;Smith;Atherosclerosis,2000

4. Data on file, AstraZeneca, 2000.

5. Uptake of HMG-CoA reductase inhibitor ZD4522 into hepatocytes and distribution into liver and other tissues of the rat;Nezasa;Atherosclerosis,2000

Cited by 291 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell Membrane-Derived Nanoparticles as Biomimetic Nanotherapeutics to Alleviate Fatty Liver Disease;ACS Applied Materials & Interfaces;2024-07-18

2. Effect of Statin Lipophilicity on the Proliferation of Hepatocellular Carcinoma Cells;Biology;2024-06-19

3. Pharmacokinetic and Safety Comparison of Fixed‐Dose Combination of Cilostazol/Rosuvastatin (200 + 20 mg) Versus Concurrent Administration of the Separate Components in Healthy Adults;Clinical Pharmacology in Drug Development;2024-03-12

4. Pharmacokinetics and Bioequivalence Evaluation of Two Rosuvastatin Calcium 20 mg Tablets: A Single Oral Dose, Randomized-Sequence, Open-Label, Two-Period Crossover Study in Healthy Volunteers under Fasting Conditions;Journal of Biosciences and Medicines;2024

5. Impact assessment of metabolite instability in the development and validation of LC–MS/MS bioanalytical assays for measurement of rosuvastatin in human plasma and urine samples;Biomedical Chromatography;2023-11-02